Revenue: The sum of all revenue fields included for a company's operating activities.
Ligand Pharmaceuticals Incorporated (LGND) had Revenue of $45.33M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$45.33M |
$-42.45M |
|
$4.85M |
|
$40.48M |
|
$81.55M |
|
$-36.22M |
|
$-13.96M |
|
$-50.18M |
|
$-37.81M |
|
$-42.45M |
|
$-42.45M |
|
$-42.45M |
|
$-28.18M |
|
$-36.22M |
|
$-28.15M |
|
19.19M |
|
19.19M |
|
$-2.21 |
|
$-2.21 |
|
| Balance Sheet Financials | |
$309.32M |
|
$3.62M |
|
$596.12M |
|
$905.43M |
|
$58.68M |
|
-- |
|
$51.22M |
|
$109.90M |
|
$795.53M |
|
$435.60M |
|
$795.53M |
|
19.28M |
|
| Cash Flow Statement Financials | |
$-25.45M |
|
$4.89M |
|
$-4.75M |
|
$72.31M |
|
$47.99M |
|
$-24.32M |
|
$7.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.27 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
89.30% |
|
-79.89% |
|
-79.89% |
|
-- |
|
-110.69% |
|
-93.64% |
|
$-25.66M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
0.33 |
|
1.06 |
|
85.03 |
|
-5.34% |
|
-9.75% |
|
-4.69% |
|
-5.34% |
|
$41.27 |
|
$-1.34 |
|
$-1.33 |
|